Patent details

EP1784396 Title: PYRAZOLE-SUBSTITUTED AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1784396
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP05782821.2
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
15/08/2005
Grant date:
22/12/2010
EP Publication Date:
22/12/2010
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
22/12/2010
EP B1 Publication Date:
22/12/2010
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
23/02/2011
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
14/08/2025
Lapsed By Expiration Date:
15/08/2025
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
16/06/2023
 
 

 

Name:
Pfizer, Inc.
Address:
66 Hudson Boulevard East, 10001-2192, New York, NY, United States of America (US)

Historical Applicant/holder

From:
22/12/2010
To:
16/06/2023

 

Name:
Pfizer, Inc.
Address:
235 East 42nd Street, NEW YORK, NY 10017, United States of America (US)

Domicile Holder

Name:
ir. F.A. Geurts c.s.
From:
22/12/2010
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
CUI, Jingrong Jean, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

2

Name:
FUNK, Lee Andrew, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

3

Name:
JIA, Lei, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

4

Name:
KUNG, Pei-Pei, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

5

Name:
MENG, Jerry Jialun, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

6

Name:
NAMBU, Mitchell David, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

7

Name:
PAIRISH, Mason Alan, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

8

Name:
SHEN, Hong, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

9

Name:
TRAN-DUBE, Michelle Bich, Pfizer Global R&D
Address:
SAN DIEGO, CA 92121, United States of America (US)

Priority

1

Priority Patent Number:
690803 P
Priority Date:
14/06/2005
Priority Country:
United States of America (US)

2

Priority Patent Number:
605244 P
Priority Date:
26/08/2004
Priority Country:
United States of America (US)

Classification

Main IPC Class:
C07D 401/14;
IPC or IDT classification:
A61K 31/4439; A61P 35/00; C07D 401/04;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
34/25
Publication date:
20/08/2025
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
2011/10
Publication date:
09/03/2011
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
2010/45
Publication date:
29/12/2010
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201116
Publication date:
20/04/2011
Description:
Document reprinted after correction (B8, B9)

2

Issue number:
201051
Publication date:
22/12/2010
Description:
Grant (B1)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202301234A
Date Registered:
16/06/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
11/07/2024
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Master Data Center
Filing date Document type Document Description Number of pages File Type
11/03/2011 Incoming Correspondence Paper Other 1 PDF /1/2/8/2/8/0505782821/docs/ep05782821.2_0_incomingcorrespondencepaper20110311.pdf
23/02/2011 Claims Translated claims 13 PDF /1/2/8/2/8/0505782821/docs/ep05782821.2_1_claims20110223.pdf
23/02/2011 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /1/2/8/2/8/0505782821/docs/ep05782821.2_2_incomingcorrespondencepaper20110223.pdf
23/02/2011 Outgoing Correspondence Outgoing Letter 1 PDF /1/2/8/2/8/0505782821/docs/ep05782821.2_3_outgoingcorrespondence20110223.pdf